Lir Life Sciences Corp. (CVE:SKNY) | WebDisclosure

Basculer en Français

11243	Companies
249478	Keywords
177546	Articles
135282	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

PRESS RELEASE

published on 01/30/2026 at 00:00, 8 months 29 days ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
LIR Life Sciences Corp. announces positive interim results from a mouse study on CPP-enabled, needle-free delivery of GLP/GIP therapies, demonstrating glucose control potential

Interim Results Lir Life Sciences Corp. GLP/GIP Therapies CPP-enabled Delivery Skin-applied Formulation
BRIEF

published on 01/23/2026 at 00:05, 9 months 5 days ago

LIR Life Sciences finalise le protocole d'étude pour l'évaluation des agents transdermiques

Administration Transdermique LIR Sciences De La Vie Macromolécules Thérapeutiques Modèle De Peau De Porc Thérapies Sans Aiguilles
BRIEF

published on 01/23/2026 at 00:05, 9 months 5 days ago

LIR Life Sciences Finalizes Study Design for Evaluating Transdermal Agents

Transdermal Delivery LIR Life Sciences Therapeutic Macromolecules Porcine Skin Model Needle-free Therapies
PRESS RELEASE

published on 01/23/2026 at 00:00, 9 months 5 days ago

LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
LIR Life Sciences Corp. announces study design for transdermal penetration of therapeutic macromolecules using ex vivo porcine skin. Focus on needle-free delivery strategies for larger therapeutics

Needle-free Delivery LIR Life Sciences Therapeutic Macromolecules Transdermal Penetration Ex Vivo Porcine Skin
BRIEF

published on 01/16/2026 at 00:05, 9 months 12 days ago

LIR Life Sciences lance une étude animale sur les thérapies transdermiques contre l'obésité

Administration Transdermique Thérapie De L'obésité Étude Animale LIR Sciences De La Vie Basé Sur Les BPL/BPI
BRIEF

published on 01/16/2026 at 00:05, 9 months 12 days ago

LIR Life Sciences Initiates Animal Study on Transdermal Obesity Therapies

Transdermal Delivery Obesity Therapy Animal Study LIR Life Sciences GLP/GIP-based
PRESS RELEASE

published on 01/16/2026 at 00:00, 9 months 12 days ago

LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies
LIR Life Sciences Corp. announces a controlled comparative animal study to evaluate needle-free transdermal delivery of GLP/GIP-based obesity therapies. Study aims to advance transdermal platform and simplify treatment for obesity

Lir Life Sciences Corp. Obesity Therapies GLP/GIP-based Controlled Study Needle-free Transdermal Delivery
BRIEF

published on 01/09/2026 at 00:05, 9 months 19 days ago

LIR Life Sciences collabore avec Neuland Labs au développement de peptides

LIR Sciences De La Vie Laboratoires Neuland Peptides Pénétrant Dans Les Cellules Plateforme Transdermique Collaboration En R&D
BRIEF

published on 01/09/2026 at 00:05, 9 months 19 days ago

LIR Life Sciences Collaborates with Neuland Labs on Peptide Development

R&D Collaboration LIR Life Sciences Neuland Laboratories Cell Penetrating Peptides Transdermal Platform
PRESS RELEASE

published on 01/09/2026 at 00:00, 9 months 19 days ago

LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
LIR Life Sciences Corp. enters R&D Agreement with Neuland Labs for peptide formulations. Neuland Labs to provide services for preclinical evaluation and future collaboration

Lir Life Sciences Corp. Neuland Labs R&D Agreement Peptide Formulations Preclinical Evaluation

Accesswire

Published on 10/28/2026 at 12:30, 5 hours 31 minutes ago

Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 5 hours 31 minutes ago

AI/ML Innovations Announces Advance Notice Provisions
Published on 10/28/2026 at 12:30, 5 hours 31 minutes ago

Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out
Published on 10/28/2026 at 12:30, 5 hours 31 minutes ago

Ameriwest Reports Additional High-Grade Copper Results from Historical Drill Core at Bornite Including 71.0 Feet (21.6 Meters) at 8.08% CuEq
Published on 10/28/2026 at 12:15, 5 hours 46 minutes ago

BULGOLD Expands Strategic Exploration Position Around the Lutila Gold Project with Two New Exploration Licences

View all ACCESSWIRE

EQS Group

Published on 10/28/2026 at 17:45, 16 minutes ago

EQS-Adhoc: Airbus reports Nine-Month (9m) 2026 results
Published on 10/28/2026 at 17:16, 44 minutes ago

Holding(s) in Company
Published on 10/28/2026 at 17:10, 51 minutes ago

DigiKey to Showcase European Growth, Innovation and the Destination DigiKey Experience at electronica Munich 2026
Published on 10/28/2026 at 17:00, 1 hour 1 minute ago

NVision Unveils First Manufacturable Molecular Qubit, Breakthrough Validated in Peer-Reviewed Nature Paper
Published on 10/28/2026 at 16:41, 1 hour 19 minutes ago

SMT Scharf AG adjusts its forecast for FY 2026 and continues to implement strategic initiatives

Les Echos

Published on 10/28/2026 at 17:56, 5 minutes ago

OPR - Mise à disposition de l'addendum au rapport d'expertise indépendante
Published on 10/28/2026 at 17:45, 16 minutes ago

VOGO obtains FIBA (International Basketball Federation) Approval for its Instant Replay System.
Published on 10/28/2026 at 17:45, 16 minutes ago

Successful issue of a € 6.0 billion bond as part of the financing of the PTC acquisition
Published on 10/28/2026 at 17:45, 16 minutes ago

Succès de l’émission obligataire de 6,0 milliards d’euros dans le cadre du financement de l’acquisition de PTC
Published on 10/28/2026 at 17:45, 16 minutes ago

VOGO obtient la certification Instant Replay System de la FIBA (Fédération Internationale de Basketball).

View all LES ECHOS COMFI WIRE